Pulmonary embolism pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 34: | Line 34: | ||
*Current research suggests that a pulmonary embolism arises through the following progression of events.<ref name="pmid19041539">{{cite journal |author=Fengler BT, Brady WJ |title=Fibrinolytic therapy in pulmonary embolism: an evidence-based treatment algorithm |journal=Am J Emerg Med |volume=27 |issue=1 |pages=84–95 |year=2009 |month=January |pmid=19041539 |doi=10.1016/j.ajem.2007.10.021 |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-6757(07)00699-7 |accessdate=2011-12-21}}</ref> | *Current research suggests that a pulmonary embolism arises through the following progression of events.<ref name="pmid19041539">{{cite journal |author=Fengler BT, Brady WJ |title=Fibrinolytic therapy in pulmonary embolism: an evidence-based treatment algorithm |journal=Am J Emerg Med |volume=27 |issue=1 |pages=84–95 |year=2009 |month=January |pmid=19041539 |doi=10.1016/j.ajem.2007.10.021 |url=http://linkinghub.elsevier.com/retrieve/pii/S0735-6757(07)00699-7 |accessdate=2011-12-21}}</ref> | ||
[[File:PE.png| | [[File:PE.png|650px]] | ||
===Comorbidites=== | ===Comorbidites=== | ||
Revision as of 15:28, 7 October 2012
|
Pulmonary Embolism Microchapters |
|
Diagnosis |
|---|
|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
|
Treatment |
|
Follow-Up |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Pulmonary embolism pathophysiology On the Web |
|
Directions to Hospitals Treating Pulmonary embolism pathophysiology |
|
Risk calculators and risk factors for Pulmonary embolism pathophysiology |
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Pulmonary embolism occurs when there is an acute obstruction of the pulmonary artery or one of its branches. It is commonly caused by a venous thrombus that has dislodged from its site of formation and embolized to the arterial blood supply of one of the lungs. The process of this formation is termed thromboembolism.
Pathophysiology
Overview of Formation
- Most pulmonary embolisms commonly originate in the iliofemoral vein, deep within the vasculature of the lower extremity.
- Less commonly, a pulmonary embolism may also arise in the upper extremity veins, renal veins, or pelvic veins.
- The nature of the clinical manifestation of a pulmonary embolism depends on a number of factors:[1]
- The presence of any preexisting cardiopulmonary conditions.
- The role of chemical vasoconstriction as it is insinuated by platelets releasing serotonin and thromboxane which adhere to the embolus.
- The presence of pulmonary artery dilatation and subsequent reflex vasoconstriction.
- The size of the embolus and the nature to which it occludes the vascular tree and its subsequent branches.
- After formation, a thrombus will travel from the site of origin and circulate through the inferior vena cava into the right ventricle where it will lodge.[2]
- A pulmonary embolism can occur in singularity or in multiplicity depending on the patient. Size and physiologic impact will hinge largely on the individual patient and subsequent anatomy of the vasculature. [2]
Physiologic Complications
- Hemodynamic complication arise as a result of the obstruction of flow within the pulmonary arteries.
- When there is a 50-60% reduction in perfusion, the following complications may arise:[2]
- Increased resistence in the pulmonary vessels
- Severe pulmonary hypertension
- Right ventricular strain
- Cardiac heart failure
- Vasoconstriction
- In 10% of all pulmonary embolism cases, the pulmonary embolism develops into pulmonary infarction. This is an exceedingly rare complication.[2]
- Long term complications:[2]
Mechanism
- Current research suggests that a pulmonary embolism arises through the following progression of events.[3]
Comorbidites
- In circumstances where more than two-thirds of the pulmonary artery is occluded, in order to preserve pulmonary perfusion, the right ventricle adapts to:
- Generate a systolic pressure (SBP) in excess of 50 mmHg
- Maintain a mean pulmonary artery pressure approximating 40 mmHg
- Without these adapations, a pulmonary embolism will lead to right heart failure.[4]
- In patients with underlying cardiopulmonary disease, the cardiac output suffers substantial deterioration in overall output as compared to otherwise healthy individuals.
- In patients with coexisting coronary artery disease (CAD), right ventricular failure is more common following a pulmonary embolism as compared to those without coexisting CAD.
References
- ↑ Kostadima, E., & Zakynthinos, E. (2007). Pulmonary Embolism: Pathophysiology, Diagnosis, Treatment. Hellenic Journal of Cardiology, 94-107.
- ↑ 2.0 2.1 2.2 2.3 2.4 McGill University. (2004, June 24). Pulmonary Embolism. Retrieved May 7, 2012, from McGill Virtual Stethoscope Pathophysiology.
- ↑ Fengler BT, Brady WJ (2009). "Fibrinolytic therapy in pulmonary embolism: an evidence-based treatment algorithm". Am J Emerg Med. 27 (1): 84–95. doi:10.1016/j.ajem.2007.10.021. PMID 19041539. Retrieved 2011-12-21. Unknown parameter
|month=ignored (help) - ↑ Benotti JR, Dalen JE (1984). "The natural history of pulmonary embolism". Clin Chest Med. 5 (3): 403–10. PMID 6488744.